SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Cancer
Northwestern University
Northwestern University
The Netherlands Cancer Institute
University Health Network, Toronto
Duke University
Duke University
Case Comprehensive Cancer Center